Remote Ischemic Preconditioning to Improve Postoperative Recovery After Posterior Cervical Decompression for Cervical Spondylotic Myelopathy: A Multicenter, Randomized, Double-Blind, Sham-Controlled Trial (RIPCORD-CSM trial)

未提供0 个研究点目标入组 100 人开始时间: 待定

适应症

试验速览

暂无简介。

•Age 18 years or older at the time of informed consent
•Diagnosed with cervical spondylotic myelopathy based on clinical and imaging findings
•Scheduled to undergo posterior cervical decompression surgery
•Written informed consent obtained from the participant

•Previous surgery at the same level, combined anterior surgery, or concomitant spinal surgery at another site
•Emergency surgery or insufficient time to perform the RIPC procedure
•Contraindications to RIPC, including severe soft tissue injury, fracture or vascular injury, or peripheral vascular disease
•Severe cardiopulmonary, hepatic, or renal dysfunction, severe coagulopathy, pregnancy, or breastfeeding
•Expected poor follow-up adherence or poor treatment compliance
•Considered inappropriate for study participation by the principal investigator

发起方

未提供